Home › DIVERSATEK HEALTHCARE, INC. › Lasso
Lasso
DIVERSATEK HEALTHCARE, INC. · Model 1180-02 · UDI-DI 00816734021576
FDI
Prescription
10
510(k) clearances
4,658
Adverse events (10 deaths)
18
Recalls
60
Facilities
Description
Lasso Polypectomy Snare
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-10-06 | Olympus Corporation of the Americas | Sterility compromised from small holes that may occur during packaging of the device pouches into the shelf carton and/or during transportation of the shelf carton. |
| 2025-10-06 | Olympus Corporation of the Americas | Sterility compromised from small holes that may occur during packaging of the device pouches into the shelf carton and/or during transportation of the shelf carton. |
| 2021-01-19 | Boston Scientific Corporation | Packaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient. |
| 2021-01-19 | Boston Scientific Corporation | Packaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient. |
| 2021-01-19 | Boston Scientific Corporation | Packaging Incomplete Seal. Users noted an incomplete pouch seal prior to using the device in a patient. |
| 2020-07-06 | Boston Scientific Corporation | BSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr |
| 2020-07-06 | Boston Scientific Corporation | BSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr |
| 2020-07-06 | Boston Scientific Corporation | BSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr |
| 2020-07-06 | Boston Scientific Corporation | BSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr |
| 2020-07-06 | Boston Scientific Corporation | BSC has noted a potential inability to cut and remove polyps for these lots/batches. potential consequences related to the snares not performing as intended would be a prolonged pr |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.
